- Report
- November 2026
- 363 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 144 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 277 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 475 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 354 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 399 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 308 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- June 2026
- 210 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Drug Pipelines
- September 2026
- 150 Pages
Global
From €3527EUR$3,750USD£2,942GBP
- Report
- August 2026
- 30 Pages
Global
From €2586EUR$2,750USD£2,158GBP
- Report
- July 2026
- 167 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 130 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 312 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 200 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 95 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 200 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 156 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 200 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 117 Pages
Global
From €7515EUR$7,990USD£6,269GBP
- Report
- July 2026
- 200 Pages
Global
From €7515EUR$7,990USD£6,269GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more